Skip to main content
Visiomed Group SA logo

Visiomed Group SA — Investor Relations & Filings

Ticker · ALVMG ISIN · FR0013481835 LEI · 969500ZH8PE9A98GLY06 PA Human health and social work activities
Open in API
Filings indexed 337 across all filing types
Latest filing 2024-03-07 Declaration of Voting R…
Country FR France
Listing PA ALVMG

About Visiomed Group SA

https://www.kleaholding.com/

Klea Holding, formerly known as Visiomed Group SA, is an international holding company focused on the acquisition, development, and digitalization of businesses across multiple sectors. The company originated as an innovator in medical electronics, known for developing the ThermoFlash non-contact infrared thermometer. It has since transitioned its strategy to a holding structure, leveraging financial management to foster growth and value creation in its portfolio companies. While its investment scope is broad, Klea Holding maintains a significant presence in the innovative healthcare sector through subsidiaries that operate digitalized medical diagnostic centers and provide connected health and teleconsultation solutions.

Recent filings

Filing Released Lang Actions
Information relative au nombre total de droits de vote et au nombre d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release ('Communiqué de presse') dated March 7, 2024, published by VISIOMED GROUP. The core content explicitly states it is publishing 'Information relative au nombre total de droits de vote et au nombre d'actions composant son capital social' (Information relating to the total number of voting rights and the number of shares comprising the share capital), citing compliance with Article 223-16 of the AMF General Regulation. This type of mandatory disclosure regarding the total share count and voting rights is a specific corporate action announcement. Reviewing the definitions, this most closely aligns with 'Share Issue/Capital Change' (SHA) as it directly concerns the capital structure (number of shares and voting rights), or potentially a general 'Regulatory Filing' (RNS) if SHA is too specific for a simple rights update. However, since it details the exact number of shares and voting rights, it is a direct notification about the capital structure, making SHA the most appropriate fit among the specific options, although it is not strictly a new issue or split, but a mandatory update on the existing structure. Given the options, 'SHA' (Share Issue/Capital Change) covers fundamental changes or updates to the capital base, which includes the total number of shares and voting rights. If a more specific 'Capital Structure Update' existed, it would be better, but SHA is the closest fit for mandatory capital structure reporting.
2024-03-07 French
Visiomed Group met en oeuvre un nouveau contrat de liquidité avec la société TP ICAP EUROPE
Regulatory Filings Classification · 99% confidence The document is a press release ("Communiqué de presse") announcing a change in a financial arrangement: Visiomed Group is terminating an old liquidity contract with PORTZAMPARC and implementing a new liquidity contract with TP ICAP EUROPE, effective February 19, 2024. This announcement details the assets transferred to the new contract and references compliance with AMF (Autorité des marchés Financiers) decisions regarding liquidity contracts. This type of announcement, dealing with the mechanics of market making or share liquidity management, is a specific corporate action. It is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS). It most closely relates to capital structure management or financing activities, but specifically concerns the mechanism for maintaining market liquidity for its shares. Given the options, this is a specific corporate action related to financing/capital management, but since it is a formal announcement about a specific financial service contract (liquidity provider), it fits best under Capital/Financing Update (CAP) as it directly impacts how the company's shares are traded and supported in the market, or potentially Regulatory Filings (RNS) if CAP is too broad. However, since it details the setup of a liquidity contract, which is a financing/market support mechanism, CAP is the most appropriate specific category over the general RNS fallback. The document length is short (under 4000 chars) and it is an announcement, not the underlying contract itself.
2024-02-16 French
Visiomed Group poursuit sa trajectoire de forte croissance avec un chiffre d'affaires en progression de 38% en 2023
Earnings Release Classification · 100% confidence The document is a press release ("Communiqué de presse") dated February 13, 2024, presenting the unaudited revenue figures for the full year 2023 ("chiffre d'affaires non audité de l'année 2023"). It provides key financial highlights (revenue growth, patient volume) and outlook for 2024. This format, focusing on preliminary, summarized results for a period (in this case, the full year) before the official comprehensive filing (like a 10-K or IR), strongly aligns with an Earnings Release (ER). It is not a full Annual Report (10-K), a comprehensive Interim Report (IR), or a mere announcement of a report (RPA), as it contains the actual summarized results. FY 2023
2024-02-13 French
Visiomed Group announces strong revenues growth in 2023
Earnings Release Classification · 98% confidence The document is explicitly titled "Press release" and announces "strong revenues growth in 2023" with key financial highlights (+38% sales growth, €13.5 million consolidated sales) and future outlook. It presents unaudited sales figures for the full year 2023. This format, focusing on key results immediately following the period end, aligns perfectly with an Earnings Release (ER), which provides initial, high-level financial results before a comprehensive report (like an IR or 10-K) is filed. It is too brief and focused on highlights to be a full Interim Report (IR) or Annual Report (10-K). Since it is a press release announcing results, ER is the most appropriate classification. FY 2023
2024-02-13 English
Retrouvez le replay de l'interview de Thomas Picquette à l'occasion du Retail Day organisé par EuroLand Corporate et Bourse Direct
Regulatory Filings Classification · 99% confidence The document is a press release ("Communiqué de presse") dated February 12, 2024, announcing the availability of the replay of an interview given by the company's Secretary General (Thomas Picquette) during the 'Retail Day' event organized by EuroLand Corporate and Bourse Direct. The content focuses on providing access to a recording of a discussion about company strategy and stock performance, rather than being a formal financial report (like 10-K or IR) or a transcript of an earnings call (CT). Since it is an announcement about an event/interview replay being made available, and it doesn't fit the specific categories like ER, IP, or CT, it falls best under the general regulatory/corporate announcement category, RNS, or potentially LTR if the interview was related to a specific legal/regulatory event, but RNS is the most appropriate fallback for general corporate news releases that don't fit elsewhere. Given the nature of providing access to an interview replay, it is a corporate communication, making RNS the best fit as a general regulatory filing/announcement.
2024-02-12 French
Information relative au nombre total de droits de vote et au nombre d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release ("Communiqué de presse") dated February 6, 2024, published by VISIOMED GROUP. The core content explicitly states it is publishing information regarding the 'nombre total de droits de vote et au nombre d'actions composant son capital social' (total number of voting rights and shares comprising the share capital), in compliance with Article 223-16 of the AMF General Regulation. This type of mandatory disclosure regarding the total share count and voting rights is a specific corporate action announcement. It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV). It most closely aligns with announcements related to capital structure changes or mandatory regulatory disclosures that aren't covered by other specific codes. Since it details the exact number of shares and voting rights, it relates directly to the share capital structure. The closest fit among the provided codes is 'Share Issue/Capital Change' (SHA), as changes in the total number of shares and voting rights are fundamental aspects of capital structure reporting. However, given the specific nature of reporting the total share count as mandated by regulators (often done monthly or semi-annually), and the fact that it is a short press release announcing this specific data point, it could also be considered a general regulatory filing (RNS). Comparing SHA and RNS: SHA is for *changes* (issues, splits), while this is a periodic *reporting* of the current state. Since the document is short and is a regulatory disclosure about the capital base, 'Share Issue/Capital Change' (SHA) is a strong candidate if the number implies a recent change, but 'Regulatory Filings' (RNS) is often used for mandatory, non-financial periodic updates. Given the explicit focus on the total share count and voting rights, which is a key component of capital structure reporting, SHA is slightly more specific than the general RNS fallback. However, looking closely at the definitions, SHA is for 'Announcement regarding new share issues, stock splits, or other capital changes.' This document reports the *current total*, not necessarily a recent change event, making RNS a safer general regulatory filing category if SHA doesn't perfectly fit the 'change' aspect. Let's re-evaluate: This is a mandatory disclosure of the total share count. This often falls under general regulatory announcements. Since it's not a dividend, financing event, or management change, RNS (Regulatory Filings / miscellaneous) is the most appropriate fallback for mandatory, non-specific disclosures. The document length is short (2501 chars), supporting the idea that it's an announcement rather than a full report.
2024-02-06 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.